<DOC>
	<DOCNO>NCT02674243</DOCNO>
	<brief_summary>This prospective randomize control trial study . The aim study evaluate efficacy Iodopovidone solution pleurodesis palliative malignant pleural effusion ( MPE ) patient compare Talc . All adult patient diagnose MPE cytology regardless primary tumor December 1 , 2015 November 29 , 2016 Maharaj Nakorn Chiang Mai Hospital , Chiang Mai University , Chiang Mai , Thailand enrol study . The inform consent apply patient treatment . Patients randomize two group ; Iodopovidone group ( intervention group ) Talc group ( control group )</brief_summary>
	<brief_title>Efficacy Iodopovidone Versus Talc Palliative Malignant Pleural Effusion</brief_title>
	<detailed_description>Background Rationale : Malignant pleural effusion ( MPE ) define present malignant cell pleural effusion . It usually find advanced stage cancer cancer pleura . Most common primary tumor cause MPE lung cancer ( 37 % ) follow breast cancer ( 16 % ) . From previous study , MPE diagnose , median survival 3-12 month depend primary tumor . In lung cancer , median survival stage IV MPE 4 month . However , quality life patient also important . These patient le suffer MPE . In recent era , chemotherapy , target therapy immunotherapy useful advanced stage cancer patient . They prolong survival patient . Therefore , pleurodesis role palliative treatment hop patient good quality life . Talc ( compose oxygen , silicate , magnesium carbon ) use one common substances chemical pleurodesis since 1935 Norman Bethune high efficacy ( 90 % ) . However , cause serious complication acute respiratory distress syndrome ( ARDS ) . Although incidence ARDS high , make patient die , therefore , substance study instead use Talc . Iodopovidone one interesting substance use pleurodesis substance since 2006 . It low cost , available . One meta-analysis 13 observational study 499 patient find iodopovidone safe success rate pleurodesis 70-100 % . The common side effect chest pain . Previously , two randomize control trial study report efficacy iodopovidone solution compare Talc pleurodesis . They find statistical significant difference either efficacy safety two substance . The limitation study small sample size , therefore , would like compare efficacy iodopovidone solution chemical pleurodesis Talc . Objectives : To compare efficacy Iodopovidone solution Talc pleurodesis MPE Research methodology : This prospective randomize control trial . All adult patient diagnose MPE cytology regardless primary tumor December 1 , 2015 November 29 , 2016 Maharaj Nakorn Chiang Mai Hospital , Chiang Mai University , Chiang Mai , Thailand enrol study . Patients randomize two group ; Iodopovidone group ( intervention group ) Talc group ( control group ) . The efficacy group compare .</detailed_description>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Povidone-Iodine</mesh_term>
	<mesh_term>Povidone</mesh_term>
	<criteria>1 . All MPE prove cytology 2 . After pleural effusion release chest tube drainage , lung fully expand 1 . Patients Karnofsky performance state â‰¤ 40 2 . History iodine allergy 3 . History morphine allergy 4 . Abnormal thyroid hormone .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Malignant pleural effusion</keyword>
	<keyword>Pleurodesis</keyword>
	<keyword>Talc</keyword>
	<keyword>Iodopovidone solution</keyword>
	<keyword>Povidone-iodine</keyword>
</DOC>